Neil Martin - Lendlease Chief Europe
| LLC Stock | 7.11 0.27 3.95% |
Executive
Neil Martin is Chief Europe of Lendlease Group
| Address | Tower Three, Barangaroo, NSW, Australia, 2000 |
| Phone | 61 2 9236 6111 |
| Web | https://www.lendlease.com |
Lendlease Management Efficiency
The company has return on total asset (ROA) of 0.012 % which means that it generated a profit of $0.012 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2607) %, meaning that it generated substantial loss on money invested by shareholders. Lendlease's management efficiency ratios could be used to measure how well Lendlease manages its routine affairs as well as how well it operates its assets and liabilities. Non Current Liabilities Total is likely to gain to about 6 B in 2024, whereas Total Current Liabilities is likely to drop slightly above 4.5 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Brent MacGregor | Medical Developments Internatio | 60 | |
| David MD | Nova Eye Medical | N/A | |
| Katherine Blacklock | Ora Banda Mining | N/A | |
| Tara Eaton | Medical Developments Internatio | N/A | |
| Russell Gregory | Talisman Mining | N/A | |
| Bill Swaim | Nova Eye Medical | N/A | |
| Scott Courtney | Medical Developments Internatio | N/A | |
| BBus CPA | Talisman Mining | N/A | |
| Greer Lucas | Medical Developments Internatio | N/A | |
| MAusiMM BS | Ora Banda Mining | 56 | |
| BSc FAICD | Nova Eye Medical | 66 | |
| Mark Flynn | Nova Eye Medical | N/A | |
| Don Watton | Nova Eye Medical | N/A | |
| Ian Harrison | Flagship Investments | N/A | |
| Liam Cook | Nova Eye Medical | N/A | |
| ACIS BSc | Talisman Mining | 49 | |
| Keith Byrne | Nova Eye Medical | N/A | |
| Wayne Pearce | Medical Developments Internatio | N/A | |
| Kimberley Menzies | Nova Eye Medical | N/A | |
| ACA ACIS | Ora Banda Mining | 49 | |
| Kate Hunt | Nova Eye Medical | N/A | |
Management Performance
| Return On Equity | -0.26 | ||||
| Return On Asset | 0.012 |
Lendlease Group Leadership Team
Elected by the shareholders, the Lendlease's board of directors comprises two types of representatives: Lendlease inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lendlease. The board's role is to monitor Lendlease's management team and ensure that shareholders' interests are well served. Lendlease's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lendlease's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony Lombardo, MD CEO | ||
| Claire Johnston, Chief Americas | ||
| Michael Vercoe, Head Relations | ||
| Celia Reynolds, Director Operations | ||
| Justin McCarthy, Head Relations | ||
| Jane Hansen, Chief Officer | ||
| Ola Fadahunsi, Director Communications | ||
| Jeff Arfsten, Chief Construction | ||
| Simon Dixon, Group Officer | ||
| Penny Ransom, Group Investments | ||
| Dale Connor, CEO Australia | ||
| Deborah Yates, Chief Officer | ||
| Neil Martin, Chief Europe | ||
| Karen Pedersen, Chief Secretary | ||
| Frank Krile, Group Officer | ||
| Justin Gabbani, Chief Management |
Lendlease Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lendlease a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.26 | ||||
| Return On Asset | 0.012 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 8.08 B | ||||
| Shares Outstanding | 690.05 M | ||||
| Shares Owned By Insiders | 0.46 % | ||||
| Shares Owned By Institutions | 55.89 % | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 0.52 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lendlease Stock Analysis
When running Lendlease's price analysis, check to measure Lendlease's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lendlease is operating at the current time. Most of Lendlease's value examination focuses on studying past and present price action to predict the probability of Lendlease's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lendlease's price. Additionally, you may evaluate how the addition of Lendlease to your portfolios can decrease your overall portfolio volatility.